Results 201 to 210 of about 4,655,222 (236)

Synthetic inhibitors of coagulation factor Xa

Expert Opinion on Investigational Drugs, 1999
The antithrombotic efficacy of low molecular weight heparins suggest that specific inhibition of blood coagulation factor Xa (fXa) is an appropriate target for drug discovery. Clinical evidence also supports the effectiveness of warfarin, an orally bioavailable non-specific anticoagulant.
openaire   +2 more sources

Factor Xa Inhibitors

2004
Jeanine M, Walenga, Walter P, Jeske, Debra, Hoppensteadt, Jawed, Fareed   +3 more
openaire   +2 more sources

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Johann S de Bono, Timothy A Yap, Shahneen Sandhu   +2 more
exaly  

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

Ca-A Cancer Journal for Clinicians, 2005
Ruth O'Regan, R M O'Regan
exaly  

Factor Xa inhibitors

Expert Opinion on Therapeutic Patents, 1999
F Al-Obeidi, JA Ostrem
openaire   +1 more source

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook
exaly  

Cysteine Proteases and Their Inhibitors

Chemical Reviews, 1997
Tanja Schirmeister, Hans-Hartwig Otto
exaly  

Boron Containing Compounds as Protease Inhibitors

Chemical Reviews, 2012
Abraham Rubinstein, Valery Dembitsky, Reem Smoum   +2 more
exaly  

Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases

Chemical Reviews, 2002
James C Powers
exaly  

Factor Xa inhibitors

Inpharma Weekly, 1992
openaire   +1 more source